Last Updated: May 6, 2026

TIZANIDINE Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

When do Tizanidine patents expire, and what generic alternatives are available?

Tizanidine is a drug marketed by Alembic, Alkem Labs Ltd, Apotex Inc, Aurobindo Pharma Ltd, Cadila Pharms Ltd, Ingenus Pharms Llc, Jubilant Generics, Ph Health, Pharmobedient, Rubicon Research, Senores Pharms, Zydus Pharms, Ani Pharms, Apotex, Aurobindo Pharma Usa, Cadila, Chartwell Rx, Dr Reddys Labs Inc, Epic Pharma Llc, Oxford Pharms, Rising, Sun Pharm Inds Inc, and Unichem Labs Ltd. and is included in twenty-nine NDAs.

The generic ingredient in TIZANIDINE is tizanidine hydrochloride. There are eleven drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the tizanidine hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Tizanidine

A generic version of TIZANIDINE was approved as tizanidine hydrochloride by DR REDDYS LABS INC on July 3^rd, 2002.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for TIZANIDINE?
What are the global sales for TIZANIDINE?
What is Average Wholesale Price for TIZANIDINE?

Summary for TIZANIDINE

US Patents:	0
Applicants:	23
NDAs:	29
Drug Prices:	Drug price information for TIZANIDINE
Drug Sales Revenues:	Drug sales revenues for TIZANIDINE
DailyMed Link:	TIZANIDINE at DailyMed

Drug patent expirations by year for TIZANIDINE

Drug Prices for TIZANIDINE

US Patents and Regulatory Information for TIZANIDINE

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ani Pharms	TIZANIDINE HYDROCHLORIDE	tizanidine hydrochloride	TABLET;ORAL	076321-001	Sep 30, 2004		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Senores Pharms	TIZANIDINE HYDROCHLORIDE	tizanidine hydrochloride	CAPSULE;ORAL	213365-001	May 13, 2024	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Aurobindo Pharma Usa	TIZANIDINE HYDROCHLORIDE	tizanidine hydrochloride	TABLET;ORAL	076282-001	Dec 16, 2003		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

DrugChatter Q&A for TIZANIDINE

Can you take tizanidine and tramadol together?

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.